| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Citalopram hydrobromide (substance) |
Is a |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram poisoning |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Accidental citalopram poisoning |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Intentional citalopram poisoning |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| intoxication par le citalopram d'intention indéterminée |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram adverse reaction |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Allergy to citalopram (finding) |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram overdose |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Accidental citalopram overdose |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Intentional citalopram overdose |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| surdose de citalopram d'intention indéterminée |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing citalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Product containing precisely citalopram (as citalopram hydrochloride) 40 milligram/1 milliliter conventional release oral drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Accidental citalopram poisoning |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Intentional citalopram poisoning |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram hydrochloride (substance) |
Is a |
False |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Allergy to citalopram (finding) |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
|
| Citalopram-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrochloride) 40 milligram/1 milliliter conventional release oral drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing only citalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing only citalopram in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing citalopram in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citalopram (as citalopram hydrobromide) 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Citalopram (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]